Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Chatter among pharmaceutical giants like Pfizer, Astrazeneca, Bayer and GSK have analysts wondering if big drug mergers are around the corner.